For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes increasingly crucial. While these pills may offer temporary relief, their potential ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx works ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug, suzetrigine, ...

On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by ...

Megan Hodge’s first bout of intense pain arrived when she was in her mid-20s. Hodge and her husband were getting ready to visit family for Thanksgiving. Though Hodge had been dealing with a variety of ...

A survey revealed a third (33%) of post-surgery patients were interested in trying a patient-controlled liquid opioid dispenser device (PCDD) for post-surgical pain management, and 57% of nurses rated ...

Over-the-counter pain relievers can provide short-term relief for issues like headaches and muscle aches, but should not be used for more than a few days without consulting a doctor. It’s important to ...